135 related articles for article (PubMed ID: 36788061)
21. Programmed cell death-ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics.
Mou H; Yang QA; Yu L; Wang T; Liu K; Shen R; Pan X; Dai Y; Wan Q; Zhou F; Qian L; Chen D; Yau T; Dong X; Wang X; Wang S
J Gastroenterol Hepatol; 2021 Sep; 36(9):2601-2609. PubMed ID: 33656759
[TBL] [Abstract][Full Text] [Related]
22. ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma.
Iseda N; Itoh S; Yoshizumi T; Yugawa K; Morinaga A; Tomiyama T; Toshima T; Kohashi K; Oda Y; Mori M
Hepatol Commun; 2021 Apr; 5(4):675-688. PubMed ID: 33860125
[TBL] [Abstract][Full Text] [Related]
23. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
Bi M; Zhao S; Said JW; Merino MJ; Adeniran AJ; Xie Z; Nawaf CB; Choi J; Belldegrun AS; Pantuck AJ; Kluger HM; Bilgüvar K; Lifton RP; Shuch B
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2170-5. PubMed ID: 26864202
[TBL] [Abstract][Full Text] [Related]
24. [A case of sarcomatoid combined hepatocellular-cholangiocarcinoma].
Jeong BJ; Hyun DH; Lee KW; Ryu ST; Lee JW; Lee JI; Jeong S; Lee DH; Kim PS; Kim HG; Kim YS; Kim JM
Korean J Gastroenterol; 2004 Jan; 43(1):56-60. PubMed ID: 14745254
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of the tumor immune microenvironment in pulmonary pleomorphic carcinoma.
Amemiya R; Miyoshi T; Aokage K; Suzuki J; Hoshino H; Udagawa H; Tane K; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Goto K; Ikeda N; Tsuboi M; Ishii G
Lung Cancer; 2021 Mar; 153():56-65. PubMed ID: 33454518
[TBL] [Abstract][Full Text] [Related]
26. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
[TBL] [Abstract][Full Text] [Related]
27. Programmed death ligand 1/indoleamine 2,3-dioxygenase 1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid features.
Kiyozawa D; Takamatsu D; Kohashi K; Kinoshita F; Ishihara S; Toda Y; Eto M; Oda Y
Hum Pathol; 2020 Jul; 101():31-39. PubMed ID: 32360490
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma.
Wang JP; Yao ZG; Sun YW; Liu XH; Sun FK; Lin CH; Ren FX; Lv BB; Zhang SJ; Wang Y; Meng FY; Zheng SZ; Gong W; Liu J
World J Gastroenterol; 2020 Aug; 26(29):4327-4342. PubMed ID: 32848337
[TBL] [Abstract][Full Text] [Related]
29. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
[TBL] [Abstract][Full Text] [Related]
30. The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients.
Zhou F; Huang Y; Cai W; Li J; Su C; Ren S; Wu C; Zhou C
Lung Cancer; 2021 Mar; 153():66-72. PubMed ID: 33454519
[TBL] [Abstract][Full Text] [Related]
31. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages.
Vieira T; Antoine M; Hamard C; Fallet V; Duruisseaux M; Rabbe N; Rodenas A; Cadranel J; Wislez M
Lung Cancer; 2016 Aug; 98():51-58. PubMed ID: 27393506
[TBL] [Abstract][Full Text] [Related]
32. Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature.
Chin S; Kim Z
Int J Clin Exp Pathol; 2014; 7(11):8290-4. PubMed ID: 25550887
[TBL] [Abstract][Full Text] [Related]
33. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
Front Immunol; 2021; 12():705378. PubMed ID: 34526987
[TBL] [Abstract][Full Text] [Related]
34. High programmed death ligand 1 expression in carcinomatous components predicts a poor prognosis in pulmonary pleomorphic carcinoma.
Noguchi M; Menju T; Nakajima N; Yoshizawa A; Ohsumi A; Nakajima D; Hamaji M; Haga H; Date H
Surg Today; 2022 Jul; 52(7):1090-1095. PubMed ID: 35041089
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma.
Hisakane K; Seike M; Sugano T; Matsuda K; Kunugi S; Nakamichi S; Matsumoto M; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A
Anticancer Res; 2021 May; 41(5):2501-2509. PubMed ID: 33952478
[TBL] [Abstract][Full Text] [Related]
36. Intrahepatic sarcomatoid cholangiocarcinoma.
Sintra S; Costa R; Filipe C; Simão A
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30244221
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical study of sarcomatoid liver carcinomas.
Haratake J; Horie A
Cancer; 1991 Jul; 68(1):93-7. PubMed ID: 1710948
[TBL] [Abstract][Full Text] [Related]
38. Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma.
Liu CQ; Xu J; Zhou ZG; Jin LL; Yu XJ; Xiao G; Lin J; Zhuang SM; Zhang YJ; Zheng L
Br J Cancer; 2018 Jul; 119(1):80-88. PubMed ID: 29921949
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.
Oda H; Nakatsuru Y; Ishikawa T
Cancer Res; 1995 Feb; 55(3):658-62. PubMed ID: 7834636
[TBL] [Abstract][Full Text] [Related]
40. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]